Abstract
Although adipose tissue and cells show considerable promise for clinical translation in the emerging field of regenerative medicine, they present a challenge to the regulatory community both nationally and internationally. This commentary evaluates the status of adipose-derived therapeutics and considers regulatory approaches designed to maximize patient safety while advancing clinical translation in accordance with evidence-based medical science.
Original language | English |
---|---|
Pages (from-to) | 257-262 |
Number of pages | 6 |
Journal | Stem Cells and Development |
Volume | 29 |
Issue number | 5 |
DOIs | |
State | Published - 1 Mar 2020 |
Keywords
- adipose-derived stromal/stem cells
- cell therapy
- regenerative medicine
- regulation
- stromal vascular fraction cells